Newly diagnosed malignancy in patients with venous thromboembolism. Search or wait and see?

Thrombosis and Haemostasis

Volumn 78, Issue 1, 1997, Pages 121-125

  Prins, Martin H ^a   Hettiarachchi, Rohan J K ^a   Lensing, Anthonie W A ^a   Hirsh, Jack ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DISEASE ASSOCIATION; ENDOSCOPY; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; OCCULT CANCER; PRIORITY JOURNAL; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 0030811915     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657513     Document Type: Conference Paper

References (21)

1. Trousseau A. Phlegmasia alba dolens. Clinque Medicale de l'Hôtel-Dieu. Paris: Bailliere JB. 1865; 3:654-712.
2. Prandoni P, Lensing AWA, Büller H, Cogo A, Prins MH, Cattelan AM et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Eng J Med 1992; 327: 1128-33.
3. Bastounis EA, Karayiannakis AJ, Makri GG, Alexiou D, Papalambros EL. The incidence of occult cancer in patients with deep venous thrombosis: A prospective study. J Intern Med 1996; 239:153-6.
4. Monreal M, Lafoz E, Casals A, Inaraja L, Montserrat E, Ma Callejas J, Martorelli A. Occult cancer in patients with venous thrombosis. A systematic approach. Malignancy 1991; 67:541-5.
5. Gore JM, Appelbaum JS, Greene HL, Dexter L, Dalen JE. Occult cancer in patients with acute pulmonary embolism. Ann Intern Med 1982; 96:556-60.
6. Goldberg RJ, Seneff M, Gore JM, Anderson FA, Green HL, Wheeler HB et al. Occult malignant neoplasm in patients with deep venous thrombosis. Arch Intern Med 1987; 147:251-3.
7. Griffin MR, Stanson AS, Brown ML, Hauser MF, O'Fallon WM Anderson HN, Kazmier FJ et al. Deep venous thrombosis and pulmonary embolism. Risk of subsequent malignant neoplasms. Arch Intern Med 1987; 147:1907-11.
8. Nordstrom M, Lindblad B, Anderson H, Bergqvist D, Kjellstrom T. Deep venous thrombosis and occult malignancy: an epidemiological study. Brit Med J 1994; 308:891-4.
9. Monreal M, Salvador R, Soriano V, Sabria M. Cancer and deep venous thrombosis. Arch Intern Med 1988; 148:485.
10. Ahmed Z, Mohyuddin Z. Deep vein thrombosis as a predictor of cancer. Angiology 1996; 47:261-5.
11. Ranft J, Heidrick H. Frequency of malignant diseases in deep vein thrombosis of the lower extremity. International Angiology 1991; 10:66-8.
12. Handler S. The futility and lack of cost-effectiveness in screening for cancer. Minnesota Medicine 1992; 75:13-16.
13. Taber L, Fagerberg CJ, Gad A. et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985; 1(8433):829-32.
14. Skrabanek P. False premises and false promises of breast cancer screening. Lancet 1985; 2(8450):316-20.
15. Mera SL. Screening for cancer and pre-cancer. Brit J Biomed Sci 1995; 52:120-41.
16. Wilson JMJ, Junger G. Principles and practice of screening for disease. WHO Public Health Paper 1968;34.
17. Wardle J, Pope R. The psychological costs of screening for cancer. J Psychosom Res 1992; 36(7):609-24.
18. Hettiarachchi RJK, Prins MH, Buller HR, Prandoni P, Cate ten JW. Occult malignancy in patients with deep-vein thrombosis. Incidence and risk indicators. Abstract. XVIth Congress of the International Society on Thrombosis and Haemostasis.
19. Sannella NA, O'Connor Jr DJ. Idiopathic deep vein thrombosis: The value of routine abdominal and pelvic computed tomographic scanning. Ann Vasc Surg 1991; 5:218-22.
20. Cornuz J, Pearson SD, Creager MA, Cook EF, Goldman L. Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis. Ann Intern Med. 1996; 125:785-93.
21. Announcement. Screening for occult malignant disease in patients with symptomatic idiopathic venous thromboembolism. Thromb Haemostas 1992; 68:783.